Teladoc Soared Over 7% in Premarket Trading After Reporting Q2 Loss and Topping Revenue Estimates

3
Comment
Favorite

Teladoc Soared Over 7% in Premarket Trading After Reporting Q2 Loss and Topping Revenue Estimates

Seekingalpha2023-07-26

Teladoc (NYSE:TDOC) is up over 7% in premarket trading after reporting Q2 results that beat on both lines and updated fiscal 2023 guidance that included the consensus.For the year, the telehealth ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2354671347?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-07-26 16:37","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2354671347","market":"us","top_or_hot":-1,"title":"Teladoc Soared Over 7% in Premarket Trading After Reporting Q2 Loss and Topping Revenue Estimates","media":"Seekingalpha","content":"<div>\n<p>Teladoc (NYSE:TDOC) is up over 7% in premarket trading after reporting Q2 results that beat on both lines and updated fiscal 2023 guidance that included the consensus.For the year, the telehealth ...</p>\n\n<a href=\"https://seekingalpha.com/news/3990925-teladoc-up-6-on-earnings-beat-2023-guidance\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Teladoc Soared Over 7% in Premarket Trading After Reporting Q2 Loss and Topping Revenue Estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTeladoc Soared Over 7% in Premarket Trading After Reporting Q2 Loss and Topping Revenue Estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-07-26 16:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3990925-teladoc-up-6-on-earnings-beat-2023-guidance><strong>Seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Teladoc (NYSE:TDOC) is up over 7% in premarket trading after reporting Q2 results that beat on both lines and updated fiscal 2023 guidance that included the consensus.For the year, the telehealth ...</p>\n\n<a href=\"https://seekingalpha.com/news/3990925-teladoc-up-6-on-earnings-beat-2023-guidance\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TDOC","symbol_name":"Teladoc Health Inc.","start_time":0,"source_url":"https://seekingalpha.com/news/3990925-teladoc-up-6-on-earnings-beat-2023-guidance","article_id":"2354671347","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2354671347","pubTimestamp":1690360679,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Teladoc  is up over 7% in premarket trading after reporting Q2 results that beat on both lines and updated fiscal 2023 guidance that included the consensus.For the year, the telehealth provider projects loss per share of -$1.60 to -$1.25. -$1.34 is the consensus. For revenue, it expects revenue of $2.6B-2.675B vs $2.62B consensus. The company's revenue range was previously $2.58B-$2.675B.In the quarter, Teladoc  saw its loss narrow to ~$65.2M from ~$3.1B in the year-ago period. In Q2 2022, the c","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"TDOC":"Teladoc Health Inc."},"translate_title":"Teladoc在公布第二季度亏损和超过预期的收入后，在盘前交易中飙升超过7%","themeId":"b6251d276d524a92990b019863be720e","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TDOC":1},"content_text":"Teladoc (NYSE:TDOC) is up over 7% in premarket trading after reporting Q2 results that beat on both lines and updated fiscal 2023 guidance that included the consensus.For the year, the telehealth provider projects loss per share of -$1.60 to -$1.25. -$1.34 is the consensus. For revenue, it expects revenue of $2.6B-2.675B vs $2.62B consensus. The company's revenue range was previously $2.58B-$2.675B.In the quarter, Teladoc (TDOC) saw its loss narrow to ~$65.2M from ~$3.1B in the year-ago period. In Q2 2022, the company was hit with a ~$3B goodwill impairment charge.Teladoc (TDOC) may also benefit from a proposed rule from the Biden administration introduced Tuesday that seeks to strengthen a law that requires health plans to cover mental health benefits on the same level as physical health ones.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":3,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}